Filing Details
- Accession Number:
- 0000899243-19-004590
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-22 20:18:00
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-22 20:18:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1346302 | Xeris Pharmaceuticals Inc | XERS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289407 | M. Barry Deutsch | C/O Xeris Pharmaceuticals, Inc. 180 N. Lasalle Street, Suite 1810 Chicago IL 60601 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-19 | 5,000 | $10.00 | 28,292 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Mr. Deutsch purchased shares of common stock from the underwriters in a public offering pursuant to the registrant's Registration Statement on Form S-1 (File No. 333-229665, completed on February 19, 2019). The shares of common stock were purchased at the public offering price.
Billionaire Hedge Funds
